Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2002 Feb;22(2):116-8.

[Observation on effect of danxiaoling in supplementary treatment of intrahepatic cholestasis in pregnancy]

[Article in Chinese]
Affiliations
  • PMID: 12585148
Clinical Trial

[Observation on effect of danxiaoling in supplementary treatment of intrahepatic cholestasis in pregnancy]

[Article in Chinese]
Dian-yun Shi et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Feb.

Abstract

Objective: To evaluate the curative effect of Danxiaoling Pill (DXLP), a Chinese herbal preparation, in treating intrahepatic cholestasis in pregnancy (ICP).

Methods: Fifty-eight cases of ICP were divided randomly into two groups and treated by DXLP and Composite Yiganling as control respectively with the other identical conventional treatment. The changes of clinical symptoms, related laboratory parameters after treatment and the condition of labor were observed.

Results: The total effective rate in both groups was 100%, but the markedly effective rate in the DXLP treated group was higher than that in control group (P < 0.01). Levels of blood cholyglycine acid (CGA), alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin, total cholesterol and low density lipoprotein were all decreased in both groups after treatment, but DXL showed a better efficacy in decreasing CGA, ALT and AST than that of Yiganling. Moreover, the amniotic fluid meconium contaminated rate, premature delivery occurrence in the DXLP group were lower than those in the control group, while the weight of newborn baby was higher in the former than in the latter.

Conclusion: DXLP could effectively lower the serum bile acid and improve liver function in treating ICP.

PubMed Disclaimer

LinkOut - more resources